rdf:type |
|
lifeskim:mentions |
umls-concept:C0003591,
umls-concept:C0018802,
umls-concept:C0023820,
umls-concept:C0026565,
umls-concept:C0035647,
umls-concept:C0086418,
umls-concept:C0449432,
umls-concept:C1179435,
umls-concept:C1524073,
umls-concept:C1548799,
umls-concept:C1705248,
umls-concept:C2603343
|
pubmed:issue |
11
|
pubmed:dateCreated |
2009-10-30
|
pubmed:abstractText |
Few studies have analysed the influence of lipoprotein components (LC) on the development of congestive heart failure (HF) in large healthy populations. We examined LC together with glucose, haptoglobin (Hp), and uric acid (UA) as risk factors for HF in the Apolipoprotein MOrtality RISk (AMORIS) study. We also explored the possible interaction between these factors and the apolipoprotein B to apolipoprotein A-1 ratio (apoB/apoA-1) in HF.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1879-0844
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
11
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1036-42
|
pubmed:dateRevised |
2011-6-8
|
pubmed:meshHeading |
pubmed-meshheading:19801574-Apolipoprotein A-I,
pubmed-meshheading:19801574-Apolipoproteins B,
pubmed-meshheading:19801574-Blood Glucose,
pubmed-meshheading:19801574-Female,
pubmed-meshheading:19801574-Haptoglobins,
pubmed-meshheading:19801574-Heart Failure,
pubmed-meshheading:19801574-Humans,
pubmed-meshheading:19801574-Longitudinal Studies,
pubmed-meshheading:19801574-Male,
pubmed-meshheading:19801574-Myocardial Infarction,
pubmed-meshheading:19801574-Risk Factors,
pubmed-meshheading:19801574-Sex Factors,
pubmed-meshheading:19801574-Single-Blind Method,
pubmed-meshheading:19801574-Sweden,
pubmed-meshheading:19801574-Treatment Outcome,
pubmed-meshheading:19801574-Triglycerides,
pubmed-meshheading:19801574-Uric Acid
|
pubmed:year |
2009
|
pubmed:articleTitle |
Lipoprotein components and risk of congestive heart failure in 84,740 men and women in the Apolipoprotein MOrtality RISk study (AMORIS).
|
pubmed:affiliation |
Department of Preventive Cardiology, Centre of Preventive Medicine, Oslo University Hospital, Ulleval, Oslo N-0407, Norway. ingar.holme@uus.no
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Multicenter Study
|